From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative
Ajay Verma, Anusha Patel, Sreedhar Subramanian, Philip J Smith
Topics & Concepts
MedicineInfliximabUlcerative colitisBiosimilarInflammatory bowel diseaseInternal medicineSubcutaneous injectionColitisGastroenterologySurgeryDiseaseBiosimilars and Bioanalytical MethodsPharmaceutical studies and practicesInflammatory Bowel Disease